In view of this, our team made the case–control study in Chinese people for 3 years, found HLA-DQ rs2856718 and rs9275572 two polymorphic loci had relevance with the prognosis of LAM treatment [10], as well as GSPT1 rs33635. This evidence concerns the gene GSPT1 and lymphangioleiomyomatosis.